To investigate repair mechanisms in bleomycin-induced pulmonary fib rosis, we used mice deficient in γ−glutamyl transpeptidase (GGT -/-), a key enzyme in GSH and cysteine metabolism. Seventy-two hours after bleomycin (0.03 U/g), GGT -/-mice displayed a different inflammatory response to wild -type as judged by a near absence of neutrophils in lung tissue and bronchoalveolar lavage and a less-pronounced rise in MMP-9.
Introduction
Pulmonary fibrosis, a common final pathway of numerous acute and chronic lung injuries, is characterized by fibroblast proliferation, extracellular matrix accumulation, and distortion of the parenchymal architecture (1) . The pathogenic mechanisms underlying the fibrotic response have not been elucidated, but a number of studies have implicated an imbalance between reactive oxygen species and available antioxidant defenses, principally GSH (2-4).
γ-glutamyl transpeptidase (GGT) is a membrane-bound enzyme that plays an essential role in the metabolism of GSH. Being involved in cellular processes dependent on the oxidation/reduction of GSH, GGT is markedly upregulated in response to a variety of lung oxidant injuries including nitrogen dioxide, hyperoxia, ozone and quinones (5) (6) (7) (8) . Likewise, it has been shown that in type 2 epithelial cells GGT activity is also increased during the inflammatory phase of the bleomycin-induced lung damage in rats (9) . On the other hand, although not all of the functions of the γ glutamyl cycle are known, it has been suggested that one of the major functions of GGT is the amino acid supply through glutathione metabolism, especially cysteine (10). 4 collagen mRNA expression by decreasing both transcription rate and transcript stability (13) . Moreover, in absence or with low concentrations of cysteine, fibroblasts produce undetectable levels of α1(I) procollagen protein (14) . With these ideas in mind, we designed a study to examine the pulmonary response to a fibrogenic insult in GGTdeficient mice with the idea of evaluating the roles of decreased levels of lung GSH, and low levels of cysteine in extracellular matrix turnover. We hypothesized that GGT null mice would develop l ess fibrosis than the wild type (GGT +/+ ) mice because cysteine deficiency would impair extracellular matrix synthesis.
Some of the results of this study have been previously reported in the form of an abstract (15) .
peroxidase-conjugated streptavidin (BioGenex, San Ramon CA) was used according to manufacturer. 3-amino-9-ethyl-carbazole (AEC, BioGenex) was used as substrate (16) . The primary antibody was replaced by non-immune serum for negative control slides. Additional detail is provided in online data supplement.
Bronchoalveolar lavage (BAL)
In a parallel experiment, BAL was performed in control wild-type and GGT -/-mice, and after 3 days and 1 month of bleomycin instillation. Lungs were lavaged by flushing with 2 aliquots of 250 µl of saline solution. Additional detail is provided in online data supplement. Hematoxylin and eosin stained slides were used for differential cell counting.
Measurement of hydroxyproline
Lungs were analyzed for collagen content, as described by Woessner (17) . Data are expressed as µg of hydroxyproline/mg dry weight. Additional detail is provided in online data supplement.
Lung tissue and BAL gelatin zymography.
Lung samples from GGT +/+ and GGT -/-, both c ontrols and after 72h of bleomycin instillation were homogenized and supernatants containing 5 µg of protein were analyzed by SDS-PAGE gels (8.5%) containing gelatin (1mg/ml) and a final concentration of 0.3 mg/ml heparin (18) . For BAL zymograms, fluid samples containing 5 µg of protein also from controls and 72h bleomycin were used. Additional detail is provided in online data supplement.
GSH and cysteine measurements.
GSH and cysteine levels of lungs from bleomycin-treated and control mice were determined as described by Kleinman and Richie (19) using high performance liquid 7 chromatography (HPLC) equipped with electrochemical detector (ESA, Boston, MA).
Additional detail is provided in online data supplement.
Statistical analysis
Values are expressed as mean + standard deviation. Differences between genetically altered mice and littermates were analyzed by using the Tukey's test. A P value <0.05 was considered statistically significant.
Results
As previously described (11), GGT-deficient mice grew and gained weight slowly, and by 6-8 weeks weighed significantly less than wild-type littermates (13.7 + 3.7 g versus 20.9 + 2.9 g respectively).
GSH and cysteine determinations
Both cysteine and GSH levels were significantly decreased in the lungs from control salineinstilled GGT deficient mice in comparison with the control wild type mice (Table 1) . After 72 hours bleomycin instillation, GSH and cysteine levels were significantly decreased in both wild -type and GGT -/-mice but levels reached their respective control values one month after bleomycin treatment (Table 1) . With the exception of the GSH levels at 72
hours post-bleomycin, mutant mice had always values significantly lower than their littermates.
Lung histology and bronchoalveolar lavage
Normal non-treated lungs from GGT null mice were smaller, but did not display any differences compared to normal lungs of wild type animals ( Figures 1A and B) . At 3 days after bleomycin instillation, GGT-deficient mice and wild -type mice developed patchy areas of inflammation throughout the lung parenchyma. Figures 1C and 1D illustrate GGT -/-and wild-type mice early response to bleomycin. As shown in table 2, the severity and extent of the inflammatory response to bleomycin showed no significant differences among GGT -/-and wild-type at 72 h post-instillation. However, the type of inflammatory cell involved was different. At 3 days post-instillation, the inflammatory process in the wildtype mice was primarily characterized by accumulation of neutrophils and lymphocytes ( Figure 1E ). In contrast, inflammation in GGT -/-showed a predominance of lymphocytes and macrophages with few polymorphonuclear cells ( Figures 1F and 1G ). Similar results were revealed by the cell profile analysis from BAL fluid (Table 3) . GGT deficient mice displayed ~ half of the total cells recovered in BAL compared with the wild type, but in both, a similar percentage of increase was observed after 72h and 1 month post-bleomycin instillation. The difference in cellularity probably correlate with the GGT-null mouse phenotype mice since it also has been reported that they present a 50 % reduction in thymus and spleen cellularity (20) . However, while an important increase of lymphocytes and neutrophils was observed in the wild-type after 72 h bleomycin i nstillation, GGT-/-exhibited a noteworthy increase of lymphocytes (~40% of the total cells recovered) with a mild increase of neutrophils (Table 3 ). This divergence can not be attributed to a difference in circulating leukocytes since similar numbers are found in GGT+/+ and GGT-/-per mm (Table 2) . Likewise, the fibrosis score determined multiplying the extent of the lesion by the percent of fibrosis was also significantly reduced in the transgenic mice (510 + 756 vs 1975 + 817 from wild-type mice, p<0.01). BAL cell profile showed no difference, being macrophages most of the recovered inflammatory cells (table 3) .
Collagen content of normal and bleomycin-treated lungs.
Lung collagen accumulation was quantified by measuring hydroxyproline content ( Figure   3 ). Lung hydroxyproline in non-injured wild type and GGT-deficient mice did not show significant differences (8.5 + 0.7 and 8.8 + 0.8 µg OH-proline/mg dry weight). At 72 hours after bleomycin instillation a moderate but significant increase in lung hydroxyproline was noticed in wild-type mice when compared with non-exposed littermates (11.7 + 1.3 µg OHproline/mg dry weight; p<0.01). In contrast, no changes were observed in GGT null mice.
At one month after bleomycin exposure, lung hydroxyproline in wild-type mice was further increased as compared with 72h or saline exposed animals (15.1 + 3.8 µg OH-proline/mg dry weight; p<0.05 vs 72 h, and p<0.01 vs saline respectively). On the contrary, GGTdeficient mice showed a marginal but not significant increase of hydroxyproline content when compared to 72h or saline exposed animals ( Figure 3 ).
Zymography of lung tissue extracts and bronchoalveolar lavage
In order to analyze gelatinases behavior, lung tissue obtained from wild type and GGT active form was also observed in wild-type bleomycin treated mice as compared to GGT null mice. When samples were treated with aminophenylmercuric-acetate which promotes processing of proMMPs to lower molecular weight active forms it became evident that total MMP-9 was higher in bleomycin wild type compared to GGT-/-mice (not shown). Pro MMP-2 and MMP-2 seemed to be increased in some bleomycin treated mice mainly in wild-type animals but no statistical significant differences were found. Lower molecular weight activity bands that could represent MMP-13 because they run at the same level of MMP-13 standard (not shown) were also increased in bleomycin treated wild-type animals as compared to both control and bleomycin treated GGT null mice ( Figure 4A ). All bands were inhibited when the gels were incubated in the presence of 20 mM EDTA (not shown).
BAL fluid samples were also examined by gelatin zymography ( Figure 4B ). Pro MMP-9
was not revealed in BAL from control GGT+/+ and GGT-/-. After 72 hours bleomycin injury, wild-type exhibited an important increase of proMMP-9 and its lower molecular weight active form. By contrast, bleomycin-treated GGT -/-mice displayed a small increase of proMMP-9. By densitometric analysis a ∼9-fold difference was quantified ( Figure 4B ; P< 0.01; n=4). MMP-9 active form was increased in bleomycin injured animals both wildtype and GGT -/-mice as compared to respective controls. ProMMP-2 activity was increased in both wild-type and GGT -/-as compared to control BAL.
Localization of MMP -9 immunoreactive protein in lung tissue.
The cellular source of MMP-9 was examined by immunohistochemistry on tissue sections from wild -type and GGT -/-controls and after 72 h of bleomycin injury. Positive staining was always more prominent in wild-type bleomycin-injured mice and strong signal was observed in numerous macrophages as well as neutrophils and bronchiolar epithelial cells ( Figure 5A ). In GGT n ull bleomycin-treated lungs, MMP-9 was found primarily in scattered alveolar macrophages ( Figure 5B ). Immunohistochemical staining for MMP-9
was negative in normal lungs of both wild type and GGT null mice ( Figure 5C ). Lung tissue samples incubated with no n-immune sera were also negative ( Figure 5D ).
NAC supplementation and response to bleomycin.
Supplementation of cysteine intake with NAC normalizes the growth curve and partially reverses the phenotype of GGT -/-mice (11). Likewise, NAC supplementation of GGTdeficient mice reverses low GSH levels (21) . On the other hand, since it has been claimed that NAC may decrease the lung fibrotic response in normal rodents (22), we fed wild type and GGT null mice with NAC starting 2 days after bleomycin instillatio n. Thus, GGT -/-mice received bleomycin with their GGT null phenotype, and after the initial lung damage they received NAC. Results of this experiment are shown in table 4. NAC supplementation increased the extent of the lesion in the GGT-/-mice but the f ibrotic index was still significantly lower 1 month after bleomycin than the wild-type plus NAC.
Regarding collagen content, bleomycin injury in NAC-treated GGT -/-mice provoked a significant increase of lung hydroxyproline as compared to control saline-treated mice, (11.8 + 1.4 vs 8.8 + 0.8; p< 0.01). However, lung hydroxyproline was still significantly lower in NAC-treated GGT -/-mice compared with NAC -treated wild-type (table 4) .
In the present study we compared the initial inflammatory and late fibrotic responses to bleomycin in GGT-deficient mice and wild type littermates. Bleomycin administration to wild-type mice caused an initial pneumonitis that evolved to fibrosis. In contrast, GGT -/-developed a similar early inflammatory response as measured by severity and extent, but appeared to be largely protected from the late fibrotic effects of bleomycin.
Interestingly, the type of inflammatory cells observed at 72 hours after bleomycin instillation exhibited important differences. Thus, while in the wild-type mice there was a neutrophilic/lymphocytic inflammatory response, GGT-deficient mice displayed a predominantly mononuclear cell reaction with few polymorphonuclear cells. The early alveolitis noticed in wild-type mice is similar to that reported in this and other species where a remarkable infiltration of neutrophils characterizes the initial inflammatory response to bleomycin (23) (24) (25) .
A prominent finding of this work was the demonstration that GGT-deficient mice develop a markedly le sser fibrotic response than the wild type mice after 1 month bleomycin-induced lung injury. Thus, lung morphology in GGT -/-mice showed only few small lesions with reduced collagen staining, and lung hydroxyproline content was similar to GGT-deficient non-treated mice.
An oxidant/antioxidant imbalance has been proposed as a pathogenic mechanism contributing to lung damage and inflammation in patients with pulmonary fibrosis. In this context, and at least theoretically, GSH deficiency might enhance bleomycin-induced fibrosis since this molecule is the most important extracellular antioxidant in the lung. In fact, there is evidence suggesting that an increased oxidant burden and a deficiency of GSH may play a role in the pathogenesis of fibrosing alveolitis (2-4). Moreover, there are several findings supporting that GSH can directly affect inflammation by inhibiting the production or function of several inflammatory cytokines and chemokines, such as TNFα, MCP-1, and some chemokine receptors (26) (27) (28) . In addition, the lack of GGT impairs the mouse immune system affecting the immune responsiveness, suggesting an important immunoregulatory role for GSH (20) . Likewise, the use of exogenous antioxidants attenuates the severity of the fibrosis, and suppressed the increases in lymphocyte and neutrophil counts, in bleomycin-induced lung injury (29) . Thus, according to these studies, it would be expected that GGT-deficient mice, in opposite to our findings, would develop a more aggressive fibrosis.
Three different mechanisms may at least partially explain this paradox. In part, the reduced fibrotic response of the GGT-/-mice might be related to the differences no ticed in the early inflammatory response. As mentioned, wild-type mice displayed a neutrophilic reaction and showed more fibrosis. It has been suggested that persistence of neutrophils may enhance lung fibrosis to a number of injuries. Thus, in experimental lung fibrosis induced by silica or bleomycin, the increase of neutrophils and duration of tissue neutrophil activation has been correlated with chronic alveolitis progressing to fibrosis (30) .
Likewise, an increase of BAL neutrophils has been found in a number of interstitial lung diseases that result in fibrosis (31, 32) . Furthermore, neutrophil migration and activation is usually higher in patients with more aggressive and worse prognosis fibrotic lung disorder (33) , and increased tissue neutrophils loaded with MMP-9 and collagenase-2 are implicated in the fibrotic reaction of patients with chronic hypersensitivity pneumonitis (15) .
Another potential fibrogenic mechanism that may also contribute to the different fibrotic response found in this study is related with the participation of matrix metalloproteinases (MMPs). Particularly, an increased lung expression of MMP-9 has been demonstrated in experimental and human pulmonary fibrosis (15, 17, 34, 35) . Excessive MMP-9 activity may contribute to the loss of integrity of the basement membranes and subsequently plays a fibrogenic role. Thus, in bleomycin-induced lung fibrosis a coincidental increase of MMP-9 activity and disruption of the alveolar epithelial basement membrane has been documented (36) . On the other hand, cell surface-localized MMP-9, proteolytically cleaves latent TGF -β, a prototype of profibrotic growth factor, providing a potentially important mechanism for TGF-beta activation and tissue remodeling (37).
The possible role of MMP-9 in lung fibrogenesis is further supported by experiments performed in MMP-9-deficient m ice who develop lesser fibrotic lesions compared with MMP-9+/+ littermates when exposed to bleomycin (38) . Also, transgenic mice overexpressing IL-13 develop pulmonary fibrosis associated with MMP-9 upregulation and TGF-β activation (39) . Furthermore, in BAL fluid samples from rapidly progressive idiopathic pulmonary fibrosis, a noteworthy increase of neutrophil-derived MMP-9 activity has been characteristically detected (40) .
In this context, our findings of a different MMP-9 expression in both BAL and lung tissues of wild-type compared with GGT -/-mice support a possible role for this enzyme. GGT deficient mice displayed a lower MMP-9 expression after injury and subsequently slighter fibrosis than wild-type.
Additionally, reduced lung MMP-9 activity in GGT-/-mice can be related to the lesser neutrophilic response, as these cells are a major source of this enzyme. In this context, it has been shown that inhibition of LPS-induced airway neutrophilic infiltration in the guinea pig reduced MMP-9 activity recovered from inflamed guinea pig airways. (41) .
A third mechanism to consider for explaining the lower lung fibrotic response in GGT-/-mice is related with the role of this enzyme in cysteine homeostasis. GGT catalyzes the first step in the extracellular hydrolysis of GSH and plays a critical role in GSH recycling. GSH is synthesized de novo from an intracellular pool of glutamine, glycine and cysteine and is degraded extracellularly in a two step process catalyzed by GGT and a dipeptidase. As a result of this γ-glutamyl cycle, GSH can be degraded and its constituent aminoacids reused.
In this context, in normal conditions the extracellular space contains an available pool of cysteine which is the delimiting substrate for GSH biosynthesis.
Actually, results obtained in GGT null mice support the notion that the cleavage of GSH is a major source of circulating cysteine (11) . Without this source of reutilization of cysteine, normal dietary intake is insufficient to compensate its loss as GSH. Supporting this point of view, we found markedly decreased levels of lung cysteine in GGT -/-mice either with saline instillation (controls) or after bleomycin exposure. In addition, the increase of the fibrotic lung response after NAC supplementation in GGT deficient mice supports this notion. GGT null mice receiving NAC augmented hydroxyproline content after bleomycin injury compared with their non-treated littermates, although continued being lower than the wild-type mice as the fibrotic index did.
Lack of cysteine may have a profound effect on extracellular matrix turnover. There is evidence demonstrating that amino acid deprivation markedly decreases newly synthesized type I collagen by human lung fibroblasts, probably by intracellular degradation of improperly folded molecules (14) . Moreover, this effect was shown to be specific for collagen since fibronectin levels and total protein levels were not affected. In addition, it has been shown that depletion of amino acids also decreases α1(I) collagen mRNA levels and repletion of amino acids induces a rapid re-expression of α1(I) mRNA. More importantly, this effect seems to be critically dependent on cysteine but not of other amino acids (42) .
Cysteine deficiency may also affect cysteine -rich proteins implicated in connective tissue remodeling. For example, it has been shown that SPARC-null mice exhibited attenuated collagen accumulation after bleomycin injury (43) . SPARC, (secreted protein acidic and rich in cysteine), is a unique matricellular gycoprotein that has been implicated as playing an important role in tissue repair (44) . SPARC, is co-expressed with type I collagen, and it has been associated with tissues undergoing extracellular matrix remodeling and fibrosis (45, 46) . Likewise, decreased cysteine may limit synthesis of cysteinyl leukotrienes, which may also contribute to the protection from lung fibrosis, as it has been recently demonstrated in the leukotriene-deficient mice (47).
In conclusion, our results demonstrated that GGT -/-mice develop a markedly decreased fibrotic response after bleomycin injury. This finding was related to a lower neutrophilic alveolitis and MMP-9 expression, and a deficiency of lung cysteine, suggesting potential mechanisms for lung structural remodeling after a fibrogenic insult. GGT-deficient (GGT -/-) mice along with wild type littermates, were generated by a cross between heterozygote animals. Genotyping was performed by Southern analysis of tail DNA specimens after Bam HI digestion. Wild type and transgenic mice were maintained in a specific pathogen-free environment and fed ad libitum.
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Bleomycin treatment.
Since GGT null mice exhibit impaired growth, bleomycin dose was adjusted by weight.
Dose of bleomycin was determined from preliminary experiments with mice of similar genetic background to consistently produce lung fibrosis with a low mortality rate.
Histology.
Both lungs were fixed in 10% formaldehyde instilled intratracheally, and then submerged in the same fixative for 24 h. The tissue was embedded in paraffin, and histologic sections were examined after hematoxylin & eosin, and Masson trichrome staining.
Semi -quantitative evaluation of lung lesions.
Lung sections from bleomycin-injured and control mice were stained, coded and scored blindly for severity and extent of the lesions, and percent of fibrosis as previously described (reference 15 in the manuscript). The assessment was done on the slide scanned completely in zigzag fashion, first at X 25 and then at X 100 magnification. We first determined the percentage of the lung area, either with inflammation or fibrosis or both (extent of the lesion), and then the percentage of the abnormal lung with fibrosis. Severity of the lesions were qualitatively evaluated as slight, moderate or severe (1, 2, and 3 respectively). The percentage of fibrosis was expressed in multiples of 10. Additionally, a fibrosis score was determined by multiplying extent of the lesion X percent of fibrosis. Twice the same pathologist (MG) evaluated the percent of fibrosis with a 6 months difference. The intraclass correlation coefficient was of 0.84 (p<0.01) (1).
Measurement of hydroxyproline
Lung fragments from control and experimental mice were dried until constant weight and hydrolyzed in 6N HCl for 24 h at 110 o C. Hydroxyproline colorimetric analysis was performed as described by Woessner (reference 17 in the manuscript). Data are expressed as µg of hydroxyproline/mg dry weight.
Immunohistochemistry.
Lung sections from untreated (saline) and treated (after 72h of bleomycin instillation) wildtype and GGT -/-mice were deparaffinized, rehydrated and then blocked with 3% H 2 O 2 in methanol for 30 minutes. Antigen retrieval was performed with citrate buffer 10 mM pH 6.0 for 5 minutes in a microwave. Tissue sections were incubated with antimouse anti-MMP-9
(Chemicon, Temecula CA), at 4°C overnight. A secondary biotinylated anti-immunoglobulin followed by horseradish peroxidase-conjugated streptavidin (BioGenex, San Ramon CA) was used according to manufacturer. 3-amino-9-ethyl-carbazole (AEC, BioGenex) in acetate buffer containing 0.05% H 2 O 2 was used as substrate. The sections were counterstained with hematoxylin. The primary antibody was replaced by non-immune serum for negative control slides.
Bronchoalveolar lavage
In a parallel experiment, bronchoalveolar lavage (BAL) was performed in groups of six control wild-type and GGT -/-mice, and after 3 days and 1 month of bleomycin instillation.
Lungs were lavaged by flushing with 2 aliquots of 250 µl of sterile saline solution at 37°C through a tracheal cannula. The BAL fluid was centrifuged at 400 g for 10 min at 4°C, and
